WHO ICTRP trial
Circulating tumor cell technology to evaluate the curative effect and prognostic…
ChiCTR2000033656 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000033656 |
|---|---|
| Public title | Circulating tumor cell technology to evaluate the curative effect and prognostic value of hepatocellular carcinoma based on immunotherapy |
| Scientific title | Circulating tumor cell technology to evaluate the curative effect and prognostic value of hepatocellular carcinoma based on immunotherapy |
| Primary sponsor | The First Affiliated Hospital of Chongqing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | china |
| Conditions | hepatocellular carcinama |
| Interventions | Case series:Immunomonotherapy or combined TACE or targeted therapy |
| Registration date | Jun 7, 2020 |
| Target size | Case series:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: